You are here

Cancer

Universal Donor Immune Cells
24.07.2011

An approach developed at the Weizmann Institute could make a cancer therapy cheaper and more effective

Genes that delay cell division exhibit reduced levels of expression (left) after exposure to a second, delayed pulse of growth factor. Those in cells receiving a single pulse (right box) maintained high expression levels
21.07.2011

A gene that keeps cell division in check may hold clues to chemotherapy resistance. 

(l-r) Prof. Varda Rotter, Dr. Eldad Tzahor, Dr. Ariel Rinon, Alina Molchadsky and Dr. Rachel Sarig. Migration regulation
22.06.2011

A gene that protects us from cancer is also involved in the timing of a crucial stage of embryonic development.

Eight Hours of Resistance
25.05.2011

Why do cancer cells easily give in to the temptation to divide?
 

Prof. Roy Bar-Ziv and Dr. Lior Nissim. Identifying cancer
07.03.2011

A new genetic sensor kills only the malignant cancer cells in a test tube.

(l-r) Liat Shachnai, Natalie Yivgi-Ohana, Prof. Atan Gross, Maria Maryanovich and Dr. Yehudit Zaltsman-Amir
01.02.2011
A newly-discovered character in the cell suicide drama may be a promising target for anti-cancer drugs
Prof. Meir Wilchek
12.09.2010
In the late 1980s, Prof. Meir Wilchek  developed an immune cancer therapy that employs "T bodies" – white...
Prof. Emeritus Nechama Haran-Ghera
12.09.2010
Haran-Ghera’s research provided the scientific basis for clinical trials of erythropoietin in multiple myeloma and for testing the...
(l-r) Prof. Yosef Yarden and Dr. Yaron Mosesson. In the bubble
01.10.2009

Cells missing a recycling mechanism get trapped in a cancer-causing cycle

New Protein Partnership
10.09.2009

Weizmann Institute Scientists Discover A New Protein Partnership That Leads to Pediatric Tumor Regression

 ...

Pages